Insider Transactions in Q4 2020 at Pliant Therapeutics, Inc. (PLRX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2020
|
Hans Hull Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+2.82%
|
$7,000
$2.08 P/Share
|
|
Dec 21
2020
|
Keith Lamont Cummings Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+14.01%
|
$9,000
$2.08 P/Share
|
|
Dec 18
2020
|
Eric Lefebvre Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,500
-3.65%
|
$325,000
$26.58 P/Share
|
|
Dec 14
2020
|
Bernard Coulie President and CEO |
SELL
Open market or private sale
|
Indirect |
3,500
-0.37%
|
$94,500
$27.59 P/Share
|
|
Dec 01
2020
|
Keith Lamont Cummings Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
18,734
-27.66%
|
$543,286
$29.56 P/Share
|
|
Dec 01
2020
|
Keith Lamont Cummings Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,734
+19.81%
|
$74,936
$4.15 P/Share
|